MediWound announces $30 million registered direct offering; shares down over 7%
Source: SeekingAlpha
2025-09-29 08:57:02 ET
More on MediWound
- MediWound Is A Buy Opportunity On The Dip
- Seeking Alpha’s Quant Rating on MediWound
- Historical earnings data for MediWound
Read the full article on Seeking Alpha
For further details see:
MediWound announces $30 million registered direct offering; shares down over 7%
MediWound Ltd.
NASDAQ: MDWD
MDWD Trading
-3.6% G/L:
$17.41 Last:
18,024 Volume:
$17.70 Open:
MDWD Latest News
April 13, 2026 07:30:00 am
Newly Published U.S. Expert Consensus Aligns with MediWound's Strategy for Chronic Wound DebridementApril 02, 2026 03:26:11 pm
MediWound Reports BARDA Contract Award to Vericel for NexoBrid® Valued at up to $197 MillionMDWD Stock Data
$198,368,635
8,315,055
N/A
24
N/A
Biotechnology & Life Sciences
Healthcare
IL
Yavne
